Intellia Therapeutics vs Profluent Bio
Intellia Therapeutics vs Profluent Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Intellia Therapeutics is on 40/100 and Profluent Bio on 58/100.
Where each one leads
Intellia Therapeutics
- agent readiness: 42/100 against 22/100
- domain rating: 60/100 against 40/100
- funding raised: $310M against $150M
- LinkedIn following: 71,640 against 11,880
Profluent Bio
- our overall score: 58/100 against 40/100
At a glance
| Measure | Intellia Therapeutics | Profluent Bio |
|---|---|---|
| What it is | A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. | AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture. |
| Category | Biotech, MedTech, Genomics, Drug Discovery | Biotech, Life Science, Artificial Intelligence, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2014 | 2022 |
| Headquarters | Cambridge, United States | Emeryville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Intellia Therapeutics | Profluent Bio |
|---|---|---|
| Employees | Not published | 66 |
| Open roles | Not published | 13 |
| Total funding | $310M | $150M |
| Latest round | Series C | Series A |
| LinkedIn followers | 71,640 | 11,880 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Intellia Therapeutics | Profluent Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 40/100 | 58/100 |
| Traction | 40/100 | Not published |
| Team | 70/100 | Not published |
| Search visibility | 31/100 | 7/100 |
| Quality | 35/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 60/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Intellia Therapeutics | Profluent Bio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery | Tailwind CSS, Bootstrap |
| Analytics | Google Analytics 4, Hotjar, Fathom | Google Analytics 4 |
Intellia Therapeutics vs Profluent Bio: common questions
Which is better, Intellia Therapeutics or Profluent Bio?
On our 0-100 score Profluent Bio rates higher (58/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Intellia Therapeutics and Profluent Bio compare on the numbers?
Intellia Therapeutics leads on agent readiness (42/100 against 22/100), domain rating (60/100 against 40/100), funding raised ($310M against $150M), LinkedIn following (71,640 against 11,880). Profluent Bio leads on our overall score (58/100 against 40/100).
Read the full Intellia Therapeutics review and pricing or the Profluent Bio review and pricing. You can also browse other Intellia Therapeutics alternatives we track.